1. Home
  2. JZ vs LPCN Comparison

JZ vs LPCN Comparison

Compare JZ & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

HOLD

Current Price

$0.14

Market Cap

17.7M

Sector

Real Estate

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$2.46

Market Cap

19.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JZ
LPCN
Founded
2011
1997
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
19.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
JZ
LPCN
Price
$0.14
$2.46
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
6.3M
107.9K
Earning Date
04-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$92.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$1.81
52 Week High
$3.35
$12.37

Technical Indicators

Market Signals
Indicator
JZ
LPCN
Relative Strength Index (RSI) 41.90 54.68
Support Level N/A $2.16
Resistance Level $0.99 $3.53
Average True Range (ATR) 0.03 0.18
MACD 0.00 0.06
Stochastic Oscillator 7.93 72.03

Price Performance

Historical Comparison
JZ
LPCN

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has single operating segment: Educational content services and other services and IT-related solution services.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: